NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 905 filers reported holding NOVARTIS A G in Q4 2016. The put-call ratio across all filers is 0.81 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $3,446,000 | -3.6% | 37,744 | +1.5% | 1.38% | -14.2% |
| Q1 2019 | $3,576,000 | -88.7% | 37,193 | +0.6% | 1.60% | +6.4% |
| Q4 2018 | $31,732,000 | +885.8% | 36,980 | -2.7% | 1.51% | +12.1% |
| Q3 2018 | $3,219,000 | +12.8% | 37,995 | +0.6% | 1.35% | +7.9% |
| Q2 2018 | $2,854,000 | -2.6% | 37,783 | +4.2% | 1.25% | +0.1% |
| Q1 2018 | $2,931,000 | -2.1% | 36,250 | +1.7% | 1.25% | +2.0% |
| Q4 2017 | $2,993,000 | -0.7% | 35,644 | +1.5% | 1.22% | -3.3% |
| Q3 2017 | $3,014,000 | +3.3% | 35,103 | +0.4% | 1.26% | -2.5% |
| Q2 2017 | $2,917,000 | +6.3% | 34,946 | -5.4% | 1.30% | +5.0% |
| Q1 2017 | $2,744,000 | +1.4% | 36,952 | -0.5% | 1.24% | -2.0% |
| Q4 2016 | $2,707,000 | -8.5% | 37,150 | -0.9% | 1.26% | -8.4% |
| Q3 2016 | $2,960,000 | -4.1% | 37,480 | +0.2% | 1.38% | -7.2% |
| Q2 2016 | $3,086,000 | +16.0% | 37,404 | +1.9% | 1.48% | +0.3% |
| Q1 2016 | $2,660,000 | – | 36,721 | – | 1.48% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Martin Investment Management, LLC | 229,184 | $23,344,682 | 7.00% |
| Foresight Global Investors, Inc. | 97,500 | $9,397,737 | 5.23% |
| SCHARF INVESTMENTS, LLC | 1,425,745 | $145,226,322 | 4.34% |
| MANAGED ASSET PORTFOLIOS, LLC | 274,204 | $27,930,369 | 4.28% |
| GARLAND CAPITAL MANAGEMENT INC | 54,710 | $5,572,761 | 3.93% |
| PRENTISS SMITH & CO INC | 52,032 | $5,299,980 | 3.91% |
| WILKINS INVESTMENT COUNSEL INC | 130,950 | $13,339 | 3.61% |
| First Fiduciary Investment Counsel, Inc. | 145,731 | $14,844 | 3.48% |
| Cullen Capital Management, LLC | 2,714,809 | $276,530,464 | 3.23% |
| JOHN G ULLMAN & ASSOCIATES INC | 182,690 | $18,608,803 | 3.04% |